Andorra Health Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Andorra Health Watch.

Press releases published on May 28, 2026

May 28, 2026

BioCardia Announces Japan PMDA Record Of Advice Supports Regulatory Submission For Approval Of CardiAMP Cell Therapy For Ischemic Heart Failure

Indeterminate GlobeNewswire

May 28, 2026

PROCEPT BioRobotics® Advances Prostate Cancer Program with WATER IV Study Enrollment Completion and Expanded IDE Approval

Indeterminate GlobeNewswire

May 28, 2026

Systemic immune activation with eftilagimod alfa associated with statistically significant increased overall survival in late-stage cancer patients

Indeterminate GlobeNewswire

May 28, 2026

Cogent Biosciences Announces FDA Acceptance of New Drug Application (NDA) with Priority Review for Bezuclastinib in Combination with Sunitinib for Patients with GIST

Indeterminate GlobeNewswire

May 28, 2026

Eupraxia Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference

Indeterminate GlobeNewswire

May 28, 2026

CRISPR Therapeutics to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

May 28, 2026

Conavi Medical Reports Fiscal Second Quarter 2026 Results and Operational Highlights

Indeterminate GlobeNewswire

May 28, 2026

Thousands of people march to protest Ford’s hospital privatization, Demand he return that funding to our public hospitals

Indeterminate GlobeNewswire

May 28, 2026

Rhythm Pharmaceuticals Announces Publication of New Bardet-Biedl Syndrome Diagnostic Algorithm in the American Journal of Medical Genetics

Indeterminate GlobeNewswire

May 28, 2026

Actinogen receives positive EMA scientific advice aligned with prior FDA guidance for its Alzheimer’s disease program

Indeterminate GlobeNewswire

May 28, 2026

MediPharm Labs Reminds Shareholders of Upcoming Annual and Special Meeting

Indeterminate GlobeNewswire

May 28, 2026

Sol-Gel Reports First Quarter 2026 Financial Results and Provides Corporate Updates

Indeterminate GlobeNewswire

May 28, 2026

Enlivex Treasury Portfolio Update: RAIN Holdings Valued at Approximately $1.16 Billion; Rain Foundation Appoints Industry Leaders to Advisory Board

Indeterminate GlobeNewswire

May 28, 2026

Oruka Therapeutics to Present at the 2026 Jefferies Global Healthcare Conference

Indeterminate GlobeNewswire

May 28, 2026

TG Therapeutics to Participate in the Jefferies Global Healthcare Conference

Indeterminate GlobeNewswire

May 28, 2026

Compass Therapeutics to Participate in Upcoming June Investor Events

Indeterminate GlobeNewswire

May 28, 2026

Dyadic and Scripps Research Collaborate on Rapid-Response Hantavirus Antibody and Vaccine Development

Indeterminate GlobeNewswire

May 28, 2026

Aurora Spine Corporation Announces First Quarter FY26 Financial Results

Indeterminate GlobeNewswire

May 28, 2026

Zenas BioPharma Announces Submission of Biologics License Application (BLA) to U.S. FDA for Obexelimab in IgG4-RD

Indeterminate GlobeNewswire

May 28, 2026

NovaBridge to Present at the 2026 Jefferies Global Healthcare Conference

Indeterminate GlobeNewswire